Eugia Pharma`s Generic Neostigmine Methylsulfate Receives Approval in the U.S.
DUBLIN, June 12, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringe, the first and only FDA-approved neostigmine–glycopyrrolate combination product in the U.S.
Avet's Generic Neostigmine Methylsulfate Receives Approval in the U.S.
Enforcement Report - Week of August 24, 2022
Hikma's Generic Neostigmine Methylsulfate Receives Approval in the U.S.
Dr. Reddy Generic Neostigmine Methylsulfate Receives Approval in US
Enforcement Report - Week of June 8, 2022
Enforcement Report - Week of February 2, 2022
Indoco's Generic Neostigmine Methylsulfate Receives Approval in the US
Gland Pharma Ltd`s Generic Neostigmine Methylsulfate Receives Approval in the US